» Articles » PMID: 1472599

[Descriptive Study of Patient Compliance in Pharmacologic Antihypertensive Treatment and Validation of the Morisky and Green Test]

Overview
Journal Aten Primaria
Specialty Public Health
Date 1992 Oct 1
PMID 1472599
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To ascertain the degree of correct use of a course of medication in a sample of patients with high blood pressure attending Primary Attention consultation, and to validate the Morisk and Green completion test.

Design: This is a transversal observational study carried out in two stages, which aims to analyse the variable rate of correct following of instructions. The sample was selected at random. SITE. The study was carried out within the framework of Primary Care.

Patients: The sample was drawn from patients with high blood pressure under treatment by medication, including 96 patients of whom only 86 completed the study.

Main Measurements And Results: Measurement of the actual incidence of correct use was carried out by means of counting the pills in the patients' homes, and the theoretical incidence of correct use by means of the Morisky and Green Test. We class those who take between 80-110% of the prescribed pills as completing the course correctly. We found: 18.6% took less medication (Margin of reliability (MR) 95%: 10, 3-26.8%), 23% took more than they should (MR 95%: 14.4-32, 2%) and 58.1% took medication as instructed (MR 95%: 48-68%, without significant differences either by sex or age. The test's sensitivity in detecting those who complied with instructions was 52%, and specificity was 44.4%.

Conclusions: 1. The number of over-consumers is particularly notable. 2. Responses to the test do not show any relationship with correct use of medication in this study. 3. In our view the test could only be used in a hypothetical population where there were no over-consumers.

Citing Articles

[Study on the use of multi-compartment compliance aids to improve blood pressure values in hypertensive patients].

Martin Oliveros A, Garcia-Pastor C, Iracheta Todo M, Gomez Martinez J, Tejedor-Garcia N Farm Comunitarios. 2024; 15(1):13-21.

PMID: 39156190 PMC: 11326674. DOI: 10.33620/FC.2173-9218.(2023).03.


Outcomes of Community Pharmacy Interventions on Patients with Medicines Under Additional Monitoring.

Aizpurua-Arruti X, Benrimoj S, Goyenechea E, Isla A, Onatibia-Astibia A, Malet-Larrea A Integr Pharm Res Pract. 2024; 13:115-125.

PMID: 39101006 PMC: 11296513. DOI: 10.2147/IPRP.S466129.


Satisfaction, Qol and adherence of patients allergic to dust mites and/or pollens undergoing sublingual immunotherapy.

Garrido-Fernandez S, Fernandez D, Lopez G, Mar Escribano Rodriguez M, Delgado V, Iglesias-Souto J Immunotherapy. 2024; 16(10):693-704.

PMID: 38888502 PMC: 11404694. DOI: 10.1080/1750743X.2024.2347828.


Adherence, acceptability and tolerability of venlafaxine extended release at dose of 300 mg/day in patients with major depressive disorder.

Gainza-Tejedor I, Moreno-Flores P, Mendez-Cordovez F, Sanchez-Gravie C, Defterali C, Sanchez-Gomez P Actas Esp Psiquiatr. 2023; 51(5):193-201.

PMID: 38117259 PMC: 10803862.


Quality of measurement properties of medication adherence instruments in cardiovascular diseases and type 2 diabetes mellitus: a systematic review and meta-analysis.

Oliveira H, Hayashi D, Carvalho S, Barros R, Neves M, Andrechuk C Syst Rev. 2023; 12(1):222.

PMID: 37993931 PMC: 10664314. DOI: 10.1186/s13643-023-02340-z.